What is the difference between Anamorelin and Megestrol tablets?

Anamorelin is primarily used to treat malignancy-related weight loss and muscle loss, particularly in patients with cancer cachexia. It improves patients' nutritional status and quality of life by stimulating the appetite center and increasing appetite and food intake.

Megestrol tablets have multiple functions such as stopping bleeding, inducing ovulation, regulating menstrual cycles, promoting endometrial hyperplasia, and reducing estrogen levels. It is mainly used to treat gynecological diseases and progesterone-related conditions.

Anamulin, as a Ghrelin receptor agonist, stimulates appetite and food intake by binding to gastric Ghrelin receptors, thereby improving the patient's nutritional status. In addition, it can also promote the body's metabolic functions, including protein synthesis, energy metabolism, etc.

Megestrol tablets exert their multiple effects mainly by competitively inhibiting progesterone receptors, simulating the natural progesterone change pattern, and affecting the functional activities of the hypothalamus-pituitary-ovarian axis.

Possible side effects of anamorelin include weakness, fatigue, atrial fibrillation, etc., but they are generally mild and mostly reversible.

Megestrol tablets may cause abnormalities in liver enzyme indicators, so liver function needs to be monitored. At the same time, because it is a progesterone drug, long-term use may cause problems such as edema and blood clots.

Anamorelin is primarily intended for patients with cachexia due to cancer or other severe chronic wasting diseases. Contraindications include those with congestive heart failure and myocardial infarction.

Megestrol tablets are mainly used for the treatment of gynecological diseases, especially patients with related progesterone needs. However, those with breast cancer or family history should use it with caution and regularly assess possible risks.